Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B E Willcox

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Oncogene|July 4, 2017
Multimerin-2 is a ligand for group 14 family C-type lectins CLEC14A, CD93 and CD248 spanning the endothelial pericyte interfaceK A Khan, A J Naylor, A Khan, et al.
Journal of Medicinal Chemistry|April 12, 1996
Complexes of HIV-1 reverse transcriptase with inhibitors of the HEPT series reveal conformational changes relevant to the design of potent non-nucleoside inhibitorsA L Hopkins, J Ren, R M Esnouf, et al.
European Journal of Immunology|June 1, 2001
Cytotoxic T lymphocytes recognize structurally diverse, clade-specific and cross-reactive peptides in human immunodeficiency virus type-1 gag through HLA-B53L Dorrell, B E Willcox, E Y Jones, et al.
Protein Science : a Publication of the Protein Society|December 14, 1999
Production of soluble alphabeta T-cell receptor heterodimers suitable for biophysical analysis of ligand bindingB E Willcox, G F Gao, J R Wyer, et al.
The Journal of Biological Chemistry|May 16, 2000
Classical and nonclassical class I major histocompatibility complex molecules exhibit subtle conformational differences that affect binding to CD8alphaalphaG F Gao, B E Willcox, J R Wyer, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Oncogene|July 4, 2017
Multimerin-2 is a ligand for group 14 family C-type lectins CLEC14A, CD93 and CD248 spanning the endothelial pericyte interfaceK A Khan, A J Naylor, A Khan, et al.
Journal of Medicinal Chemistry|April 12, 1996
Complexes of HIV-1 reverse transcriptase with inhibitors of the HEPT series reveal conformational changes relevant to the design of potent non-nucleoside inhibitorsA L Hopkins, J Ren, R M Esnouf, et al.
European Journal of Immunology|June 1, 2001
Cytotoxic T lymphocytes recognize structurally diverse, clade-specific and cross-reactive peptides in human immunodeficiency virus type-1 gag through HLA-B53L Dorrell, B E Willcox, E Y Jones, et al.
Protein Science : a Publication of the Protein Society|December 14, 1999
Production of soluble alphabeta T-cell receptor heterodimers suitable for biophysical analysis of ligand bindingB E Willcox, G F Gao, J R Wyer, et al.
The Journal of Biological Chemistry|May 16, 2000
Classical and nonclassical class I major histocompatibility complex molecules exhibit subtle conformational differences that affect binding to CD8alphaalphaG F Gao, B E Willcox, J R Wyer, et al.
Pageof 2